Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity
Saved in:
| Main Authors: | Radhika Gupta, BA, Laura Cesar, BA, Robert Micheletti, MD, Victoria Fang, PhD, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | JAAD International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328725000422 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review
by: Juliana West, et al.
Published: (2025-04-01) -
Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01) -
Comorbidities in hidradenitis suppurativa: Role of metabolic syndrome and sexual dysfunction disorders in postoperative healing
by: Sowmya Ravi, MPH, et al.
Published: (2025-02-01) -
AI in Hidradenitis Suppurativa: Expert Evaluation of Patient-Facing Information
by: Ezanno AC, et al.
Published: (2024-11-01) -
Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01)